Consecutive Use of TNF-Inhibitors for the Treatment of
Analysis of 1,025 recently switched PsA patients reveals second- or later-line usage of IL-17, IL-23, and JAK inhibitors growing in popularity....
Source: globenewswire.com
Stay updated with breaking news from Spherix Ps. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysis of 1,025 recently switched PsA patients reveals second- or later-line usage of IL-17, IL-23, and JAK inhibitors growing in popularity....